(LifeSiteNews) – A top vaccination official with the U.S. Food & Drug Administration (FDA) acknowledged in a recent interview that the prospect of continual booster shots to account for COVID-19 variants may well be unsustainable.
Peter Marks, director of the FDA’s Center for Biologics Evaluation & Research, told Stat News that he “would be lying to you if [I said] it doesn’t keep me up at night worrying that there is a certain chance that we may have to deploy another booster — at least for a portion of the population, perhaps older individuals — before next September, October. I’m not saying that’s what’s going to happen, but it’s what keeps me up at night, because we see how fast this virus is evolving.”
“There are probably things that can be done to optimize sequences and optimize constructs that would hopefully lead to better mRNA vaccines,” Marks said, but “we need to look at other types of vaccines. And there are those out there that might provide more durable immunity.”
“I would love to see us have a very ecumenical look over all of the available vaccines and all of the vaccines in development to try to see what’s best moving forward,” he added. “Not to diss the current mRNA vaccines, but because we owe it to the population to see what might provide the greatest breadth, depth, and duration of immunity against COVID-19.”
The director’s comments echo increasing acknowledgment of what was once derided as “misinformation,” that whatever protection the COVID vaccines do offer is much shorter than initially promised. But that is only the beginning of why the shots generate so much ongoing controversy.
Many harbor moral reservations about the use of aborted fetal cells in the COVID vaccines’ development, as well as grave concerns about the necessity and safety of the shots given the superiority of natural immunity, COVID’s low risk to most otherwise-healthy individuals, the vaccines’ failure to prevent infection, their accelerated development under former President Donald Trump’s Operation Warp Speed initiative giving them only a fraction of the evaluation and development time vaccines normally take, the lack of transparency from their manufacturers, and mounting evidence of serious adverse effects.
In March, it was found that 11,289 cases of pericarditis/myocarditis after COVID vaccination were reported to the U.S. government’s federal Vaccine Adverse Event Reporting System (VAERS) between January 1 and February 25, which was already 47% of the 24,177 reports for the same submitted in all of 2021. An April study out of Israel indicates that COVID infection alone cannot account for such cases, despite claims to the contrary.
COVID shot defenders claim that VAERS offers an exaggerated view of a vaccine’s potential risks, as anyone can submit a report without vetting it, but CDC researchers have acknowledged “high verification rate of reports of myocarditis to VAERS after mRNA-based COVID-19 vaccination,” leading to the conclusion that “under-reporting is more likely” than over-reporting.
Further, VAERS is not the only data source indicating cause for concern. Data from the Pentagon’s Defense Medical Epidemiology Database (DMED) has been similarly alarming, showing that 2021 saw drastic spikes in a variety of diagnoses for serious medical issues over the previous five-year average, including hypertension (2,181%), neurological disorders (1,048%), multiple sclerosis (680%), Guillain-Barre syndrome (551%), breast cancer, (487%), female infertility (472%), pulmonary embolism (468%), migraines (452%), ovarian dysfunction (437%), testicular cancer (369%), and tachycardia (302%).
Last month, the Japanese Society for Vaccinology published a peer-reviewed study conducted by researchers from Stanford, UCLA, and the University of Maryland, which found that the “Pfizer trial exhibited a 36% higher risk of serious adverse events in the vaccine group” while the “Moderna trial exhibited a 6% higher risk of serious adverse events in the vaccine group,” for a combined “16% higher risk of serious adverse events in mRNA vaccine recipients.”